Search Within

Sarcoma Service

Formats
  1. Journal Article (450)
  2. Meeting Abstract (430)
  3. Review (27)
  4. Editorial (9)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (945)
  2. Solid Tumor Oncology Division (945)
  3. GSK Faculty (340)
  4. Tow Center for Developmental Oncology (TCDO) (307)
  5. Hematologic Malignancies, Division of (293)
  6. Department of Pathology and Laboratory Medicine (238)

More Groups

People
  1. William Tap (378)
  2. Sandra D'Angelo (254)
  3. Mrinal Gounder (230)
  4. Ping Chi (175)
  5. Mark Dickson (172)
  6. Cristina Antonescu (136)

More People

Years
  1. 2025 (36)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (273)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (61)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (26)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (287)
  2. American Association for Cancer Research (108)
  3. Oxford University Press (92)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (42)
  6. Springer (40)

More Publishers

Results (945)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Localized and diffuse tenosynovial giant cell tumor: Real-world results from a patient observational registry
    Journal Article

    Stern, S.; McKenzie, P. F.; Bernthal, N.; O’Neill, S.; Palmerini, E.; Randall, R. L.; Tap, W.; Scharschmidt, T.; Rothschild, S.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair pathways: A key feature in a significant subset of translocation-associated sarcomas
    Journal Article

    Saoud, C.; Dermawan, J. K.; Arora, K.; Tap, W. D.; Reed, D.; Slotkin, E. K.; Wexler, L. H.; Murciano-Goroff, Y. R.; Latham, A.; Mandelker, D. L.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • Undifferentiated pleomorphic sarcoma in children and young adults: A comprehensive clinicopathologic, genomic, and epigenetic comparison with adult counterparts
    Journal Article

    Saoud, C.; Gundem, G.; Vanderbilt, C. M.; Wexler, L. H.; Reed, D. R.; Tap, W.; Singer, S.; Villafania, L. B.; Papaemmanouil, E.; Benhamida, J.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Does longitudinal NGS testing provide clinically relevant information in translocation associated sarcomas (TAS)?
    Meeting Abstract

    Yakoub, M.; Saoud, C.; Tap, W.; Wexler, L.; Hameed, M.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • What is the clinical impact of secondary genetic alterations (SGA) in translocation associated sarcomas (TAS)?
    Meeting Abstract

    Chang, H. Y.; Tap, W.; Hameed, M.; Vanderbilt, C.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • A study to learn if nirogacestat works and is safe for adult participants with desmoid tumors: A plain language summary of the DeFi study
    Editorial

    Kasper, B.; Whiting, J.; Lawson, D.; Portnoy, M.; Schuster, K.; Baumgarten, C.; Ratan, R.; Lim, A.; Cho, S.; Kummar, S.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Harmonization of the upfront osteosarcoma treatment paradigm for adolescents and young adults
    Journal Article

    Daukshus, N. P.; Avutu, V.; Long Sarro, E.; Kinnaman, M. D.; Slotkin, E. K.; Thornton, K.; Dickson, M. A.; Sklarin, N. T.; Tap, W. D.; Glade Bender, J.
    Journal of Adolescent and Young Adult Oncology (2025)

    Fulltext@MSK | Save
  • Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States
    Journal Article

    Dai, D.; Pan, I.; Freivogel, K.; Ye, X.; Tecson, K.; Tap, W.
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone
    Journal Article

    Saoud, C.; Benhamida, J.; Borsu, L.; Villafania, L.; Linos, K.; Brannon, A. R.; Sinchun, H.; Morris, C.; Vaynrub, M.; Bartelstein, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
    Journal Article

    Lopez, J. S.; Milhem, M.; Butler, M. O.; Thistlethwaite, F.; Van Tine, B. A.; D'Angelo, S. P.; Johnson, M. L.; Sato, T.; Arkenau, H. T.; Edukulla, R.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save